SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001640334-20-000164
Filing Date
2020-01-28
Accepted
2020-01-28 16:32:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A nmus_sc13da.htm SC 13D/A 31225
  Complete submission text file 0001640334-20-000164.txt   33057
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Subject) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87830 | Film No.: 20554780
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9
Business Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9 858-361-4499
Emerald Health Sciences Inc. (Filed by) CIK: 0001728413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A